|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/08 | |||
| A61K 47/14 | |||
| A61K 31/5575 | |||
| A61P 27/06 |
| (11) | Patento numeris | 2950782 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14746512.4 |
| Europos patento paraiškos padavimo data | 2014-01-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-12-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/013744 |
| Data | 2014-01-30 |
| (87) | Numeris | WO 2014/120866 |
| Data | 2014-08-07 |
| (30) | Numeris | Data | Šalis |
| 201361759129 P | 2013-01-31 | US |
| (72) |
WONG, Vernon G., US
HU, Mae W., US
HUANG, Glenn T., US
|
| (73) |
Icon Bioscience, Inc.,
1253 Reamwood Avenue, Sunnyvale, CA 94089,
US
|
| (54) | SUSTAINED RELEASE FORMULATIONS FOR THE TREATMENT OF INTRAOCULAR PRESSURE OR GLAUCOMA |
| SUSTAINED RELEASE FORMULATIONS FOR THE TREATMENT OF INTRAOCULAR PRESSURE OR GLAUCOMA |